Eagle Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$3.96M Buy
+190,546
New +$3.83M 0.02% 411
2020
Q3
Sell
-134,578
Closed -$2.61M 577
2020
Q2
$2.61M Buy
134,578
+1,394
+1% +$25K 0.01% 424
2020
Q1
$1.38M Buy
133,184
+19,232
+17% +$538K 0.01% 495
2019
Q4
$4.29M Buy
113,952
+35,643
+46% +$1.6M 0.02% 429
2019
Q3
$3.65M Buy
78,309
+4,019
+5% +$187K 0.02% 454
2019
Q2
$3.88M Sell
74,290
-1,527
-2% -$89.6K 0.02% 434
2019
Q1
$5.23M Buy
75,817
+1,905
+3% +$128K 0.03% 405
2018
Q4
$4.41M Sell
73,912
-1,607
-2% -$139K 0.03% 405
2018
Q3
$8.75M Buy
75,519
+1,395
+2% +$157K 0.04% 357
2018
Q2
$9.36M Sell
74,124
-21,390
-22% -$2.6M 0.05% 331
2018
Q1
$10.3M Buy
95,514
+11,214
+13% +$1.24M 0.06% 311
2017
Q4
$9.29M Buy
84,300
+28,063
+50% +$2.8M 0.05% 332
2017
Q3
$5.55M Buy
56,237
+1,136
+2% +$110K 0.03% 421
2017
Q2
$5.58M Buy
55,101
+169
+0.3% +$18.2K 0.03% 415
2017
Q1
$6.34M Buy
54,932
+21,417
+64% +$2.49M 0.04% 386
2016
Q4
$4.02M Buy
33,515
+5,563
+20% +$616K 0.03% 443
2016
Q3
$3.14M Sell
27,952
-874
-3% -$101K 0.02% 492
2016
Q2
$3.57M Buy
28,826
+5,271
+22% +$636K 0.02% 460
2016
Q1
$2.65M Sell
23,555
-1,539
-6% -$160K 0.02% 508
2015
Q4
$2.73M Sell
25,094
-328
-1% -$37.5K 0.02% 508
2015
Q3
$2.54M Sell
25,422
-639
-2% -$69.5K 0.02% 518
2015
Q2
$2.97M Sell
26,061
-1,552
-6% -$188K 0.02% 508
2015
Q1
$2.88M Buy
27,613
+11,707
+74% +$1.25M 0.02% 491
2014
Q4
$1.91M Sell
15,906
-10,678
-40% -$1.4M 0.01% 553
2014
Q3
$3.89M Buy
26,584
+8,298
+45% +$1.28M 0.02% 471
2014
Q2
$3.05M Sell
18,286
-2,546
-12% -$453K 0.02% 545
2014
Q1
$4.13M Sell
20,832
-905
-4% -$171K 0.02% 501
2013
Q4
$4.15M Sell
21,737
-1,054
-5% -$196K 0.02% 464
2013
Q3
$3.86M Sell
22,791
-6,244
-22% -$969K 0.02% 534
2013
Q2
$4.4M Buy
+29,035
New +$4.11M 0.03% 476

Other funds holding CLB